ecancermedicalscience

Short Communication

Cancer care during the COVID-19 pandemic: a perspective from Saudi Arabia

17 Jul 2020
Saleh A Alessy, Elizabeth A Davies, Abdul-Rahman Jazieh

The coronavirus disease 2019 (COVID-19) pandemic continues to disrupt many healthcare settings worldwide including cancer care. COVID-19 has been associated with worse outcomes amongst cancer patients. Saudi Arabia has experienced several Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks that affected the continuity of cancer care. In this paper, we describe how Saudi Arabia responded to COVID-19, how cancer care was re-restructured during this pandemic and how the recent MERS-CoV experience may have improved the Saudi response to COVID-19.

Related Articles

Priti Singh, Chaithanya Leon, Simran Kaur, Atul Batra, Prashant Tayade, Muthukrishnan Suriya Prakash, Ratna Sharma
Joseph Weygand, Yao Hao, Munir Awol, Adedayo O Joseph, Solomon Kibudde, Abba Malloum, Twalib A Ngoma, Samuel O Adeneye, Kavuma Awusi, Jumaa D Kisukari, Thokozani Mkhize, Maureen Bilinga Tendwa, Victoria Ainsworth, Azeezat Ajose, William Swanson, Stephen Avery, Rohini Bhatia, Frank Chinegwundoh, Curtiland Deville, Mohammed Saiful Huq, Heng Li, Joerg Lehmann, Christopher F Njeh, Krishni Wijesooriya, Wilfred Ngwa, Katy Graef, Janine Simons, Onyinye Balogun, Luca Incrocci